✦ LIBER ✦

One-year follow-up of the SIRIUS study: A randomized study with the sirolimus-eluting Bx VELOCITY in the treatment of patients with denovo native coronary artery lesions

✍ Scribed by David R. Holmes Jr.; Martin B. Leon; Jeffrey W. Moses; Jay Midwall; Mel Clark; Igor Palacios; Mark Bates; John Lopez; Alan C. Yeung; Richard E. Kuntz

Book ID: 119546070
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 333 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)80141-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two-year follow-up of the RAVEL study: A

Two-year follow-up of the RAVEL study: A randomized study with the sirolimus-eluting Bx VELOCITY stent in the treatment of patients with denovo native coronary artery lesions

✍ Marie-Claude Morice; Patrick Serruys; Costantino Costantini; Egon Wuelfert; Will 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

210-Day follow-up of the RAVEL study: a

210-Day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting Bx VELOCITY™ balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions

✍ Jean Fajadet; M. Perin; E.Ban Hayashi; A. Colombo; G. Schuler; P. Barragan; C. B 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 150 KB

843-6 Three-year follow-up of the RAVEL

843-6 Three-year follow-up of the RAVEL study: A randomized study with the sirolimus-elutin gBx VELOCITY™ stent in the treatment of patients with de novo native coronary artery lesions

✍ Marie-Claude Morice; Patrick Serruys; Costantino Constantini; Egon Wuelfert; Wil 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Safety and Efficacy of the 2.25-mm Sirol

Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

✍ Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Sirolimus PK trial: A pharmacokinetic st

Sirolimus PK trial: A pharmacokinetic study of the sirolimus-eluting Bx Velocity stent in patients with de novo coronary lesions

✍ George W. Vetrovec; David Rizik; Clark Williard; David Snead; Vladimir Piotrovsk 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Impact of sirolimus-eluting stents on ou

Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

✍ I. Moussa; M.B. Leon; D.S. Baim 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 48 KB